When taken daily as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. Condoms, used consistently, reduce HIV transmission by roughly 80%. By the numbers alone, PrEP offers stronger protection against HIV. But this comparison misses a critical detail: PrEP only protects against HIV, while condoms also guard against gonorrhea, chlamydia, syphilis, herpes, and HPV. The best answer depends on what you’re trying to prevent.
How PrEP and Condoms Compare for HIV
The gap in HIV protection is significant. PrEP’s 99% risk reduction comes from the CDC’s data on people who take the medication consistently. A Cochrane review of condom effectiveness found that consistent condom use reduces HIV incidence by about 80%, with estimates ranging from as low as 35% to as high as 94% depending on the study population. That wide range reflects how much real-world conditions vary.
Condoms have an additional problem that PrEP doesn’t share in the same way: the difference between perfect and typical use is steep. In studies of couples where one partner was HIV-positive, consistent condom users had an HIV transmission rate of about 1.1 per 100 person-years. Inconsistent users saw rates jump to 9.7 per 100 person-years, nearly nine times higher. A condom left in the drawer, used incorrectly, or skipped in the moment offers no protection at all.
PrEP also has an adherence problem, but it works differently. You take it hours or days before sex, not in the moment. That separation from the sexual encounter itself makes consistent use easier for many people. Still, PrEP’s effectiveness drops substantially if doses are missed. Current guidelines define adequate adherence as at least four doses per week to maintain high protective levels.
What PrEP Does Not Protect Against
PrEP does not protect against any sexually transmitted infection other than HIV. This is the single biggest limitation of choosing PrEP over condoms. Studies have documented a 41% to 72% increase in bacterial STI rates among men who have sex with men after starting PrEP, likely because some people reduce or stop condom use once they begin the medication. Among women using PrEP services in lower-income countries, new chlamydia cases occurred at a rate of more than 20 per 100 person-years.
Condoms, by contrast, create a physical barrier that reduces transmission of most STIs. They’re particularly effective against infections spread through bodily fluids (gonorrhea, chlamydia, HIV) and offer partial protection against infections spread through skin contact (herpes, HPV), though coverage depends on the area the condom covers.
This is why PrEP guidelines recommend STI screening every three to six months for anyone on the medication. If you’re using PrEP without condoms, regular testing becomes essential for catching infections early.
How PrEP Works in the Body
PrEP medications are absorbed into cells and converted into active compounds that block HIV’s ability to copy its genetic material. If HIV enters the body, it encounters these compounds in the tissue and cannot replicate or establish a permanent infection. The virus is effectively stopped before it can take hold.
Protection doesn’t kick in immediately. For receptive anal sex, oral PrEP reaches maximum protective drug levels after about 7 days of daily use. For receptive vaginal sex and injection drug use, it takes up to 21 days. This means you can’t start PrEP the day before a potential exposure and expect full protection.
An injectable form of PrEP, given as a shot every two months, has shown superior results compared to daily pills in clinical trials. It eliminates the need for daily adherence and has demonstrated HIV incidence rates of just 0.20 per 100 person-years in real-world studies among Black African women. For people who struggle with taking a daily pill, the injectable version removes the biggest barrier to effectiveness.
Why the “Which Is Better” Question Is Misleading
Framing this as PrEP versus condoms assumes you need to choose one. In practice, they address different risks and work through completely different mechanisms. PrEP provides pharmaceutical protection against a single virus. Condoms provide physical barrier protection against a broad range of infections and also prevent pregnancy. Neither one does what the other does.
Someone in a serodiscordant relationship (where one partner is HIV-positive) who is primarily concerned about HIV transmission gets the strongest protection from PrEP. Someone with multiple partners who wants broad STI protection benefits most from consistent condom use. Someone who wants maximum protection across the board uses both.
Using PrEP and condoms together brings HIV risk to near zero while also covering gonorrhea, chlamydia, syphilis, and other infections. There’s no scenario where adding one method on top of the other reduces your protection.
Practical Factors That Affect Real-World Protection
Effectiveness numbers from clinical settings don’t always translate to everyday life. For condoms, the primary failure point is inconsistency. People don’t use them every time, they put them on incorrectly, or they use expired or improperly stored products. For PrEP, the failure point is missed doses. Taking the pill fewer than four times a week drops protection significantly.
Cost and access also matter. PrEP requires a prescription, regular medical visits, blood work to monitor kidney function, and STI screening every few months. Condoms are available over the counter with no medical appointments required. For some people, the logistical demands of PrEP are a barrier. For others, the in-the-moment nature of condom use is harder to maintain.
There’s also the question of what happens when protection fails. A condom that breaks during a single encounter leaves you exposed for that encounter. Missing PrEP doses gradually lowers drug concentrations in your tissue over days, creating a window of vulnerability you might not be aware of. Both methods require a degree of ongoing commitment, just in different forms.